Attis Industries Inc.
Materials · Industrial Organic Chemicals · NY · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | |
|---|---|---|---|---|---|---|
| Revenue | $890,258 | $31.7M | $13.5M | — | $11.3M | $12,444 |
| Operating income | — | — | — | — | — | — |
| Net income | −$39.2M | −$17.7M | −$19.2M | $271,063 | $1.2M | −$26,139 |
| Total assets | $103.6M | $49.2M | $51.7M | $21.7M | $67,928 | $60,553 |
| Total liabilities | $119.0M | $56.9M | $51.6M | $15.9M | — | — |
| Equity | −$16.7M | −$10.3M | $106,663 | $5.8M | $1.5M | $1.3M |
| EPS (diluted) | — | — | $-1.33 | — | — | — |
| Shares out. | 7.3M | 23.2M | 11.4M | 1.1M | 1.1M | 1.1M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2017- Operating margin
- —
- Net margin
- −4398.8%
- Return on equity
- 234.8%
- Return on assets
- −37.8%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 114.9%
- Debt / equity
- —
- Book value / share
- $-2.27
- Revenue growth (YoY)
- −97.2%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2017- Accruals / assets
- −30.2%clean
- Piotroski F-Score
- 3/8weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 4 warning● 2 good- Negative shareholder equity
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Reported a net loss
- Revenue declined year-over-year
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Strong return on equity (>15%)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Nov 15, 2019
- NT 10-Qmissed a reporting deadline ↗Aug 15, 2019
- NT 10-Qmissed a reporting deadline ↗May 16, 2019
- NT 10-Kmissed a reporting deadline ↗Apr 2, 2019
- NT 10-Qmissed a reporting deadline ↗Nov 15, 2018
- NT 10-Qmissed a reporting deadline ↗Aug 15, 2018
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Struve Clayton A10% owner | Jul 27, 2017 | Buy | 20,389 | $0.00 |
| Davis Jackson W JrDirector | Jan 2, 2018 | Grant | 6,924 | $0.00 |
| Ardagna Joseph FrancisDirector | Jan 2, 2018 | Grant | 6,924 | $0.00 |
| Cowee Thomas JDirector | Jan 2, 2018 | Grant | 6,924 | $0.00 |
| Cosman Jeffrey ScottOfficer — CEO, Chairman | Oct 26, 2017 | Buy | 100 | $0.99 |
| Cowee Thomas JDirector | Oct 2, 2017 | Grant | 6,061 | $0.00 |
| Davis Jackson W JrDirector | Oct 2, 2017 | Grant | 6,061 | $0.00 |
| Ardagna Joseph FrancisDirector | Oct 2, 2017 | Grant | 6,061 | $0.00 |
| Davis Jackson W JrDirector | Jun 30, 2017 | Grant | 4,592 | $0.00 |
| Ardagna Joseph FrancisDirector | Jun 30, 2017 | Grant | 4,592 | $0.00 |
| Cowee Thomas JDirector | Jun 30, 2017 | Grant | 4,592 | $0.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Delisting / listing-standard noticeNov 20, 2019
- Delisting / listing-standard noticeOct 15, 2019
- Delisting / listing-standard notice · Item 5.06Aug 23, 2019
- Entered a material agreementAug 22, 2019
- Prior financials not reliable (restatement)Jul 2, 2019
- Entered a material agreement · Completed an acquisition or disposition · New financial obligationJun 5, 2019
- Delisting / listing-standard notice · Other material eventMay 23, 2019
- Prior financials not reliable (restatement)May 3, 2019
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- REVOKEDApr 15, 2020
- SC 13G/AAMENDMENT NO. 2 TO SCHEDULE 13GFeb 11, 2020
- SC 13G/AATIS 13GAJan 31, 2020
- 25-NSEJan 21, 2020
- SC 13G/ASCHEDULE 13G/AJan 8, 2020
- SC 13GDec 20, 2019
- 8-KCURRENT REPORTNov 20, 2019
- NT 10-QNOTIFICATION OF LATE FILINGNov 15, 2019
- 8-KFORM 8-KOct 15, 2019
- 8-KFORM 8-KAug 23, 2019
- 8-KFORM 8-KAug 22, 2019
- NT 10-QNOTIFICATION OF LATE FILINGAug 15, 2019
- 10-Q/AAMENDMENT NO.1 TO FORM 10-QJul 10, 2019
- 8-KJul 2, 2019
- RWREQUEST FOR WITHDRAWALJun 7, 2019
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.